Tango Therapeutics Inc’s filing revealed that its General Counsel Barry Douglas unloaded Company’s shares for reported $8289.0 on Feb 04 ’25. In the deal valued at $2.99 per share,2,774 shares were sold. As a result of this transaction, Barry Douglas now holds 68,570 shares worth roughly $0.22 million.
Then, Barry Douglas sold 2,556 shares, generating $8,081 in total proceeds. Upon selling the shares at $3.16, the General Counsel now owns 66,014 shares.
Before that, Beckman Daniella sold 4,284 shares. Tango Therapeutics Inc shares valued at $12,801 were divested by the Chief Financial Officer at a price of $2.99 per share. As a result of the transaction, Beckman Daniella now holds 154,232 shares, worth roughly $0.5 million.
Jefferies initiated its Tango Therapeutics Inc [TNGX] rating to a Buy in a research note published on July 17, 2024; the price target was $19. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in early April with a ‘”an Overweight”‘ rating. Piper Sandler began covering TNGX with “an Overweight” recommendation on February 12, 2024. B. Riley Securities started covering the stock on December 08, 2023. It rated TNGX as “a Buy”.
Price Performance Review of TNGX
On Tuesday, Tango Therapeutics Inc [NASDAQ:TNGX] saw its stock jump 27.56% to $3.24. Over the last five days, the stock has gained 58.05%. Tango Therapeutics Inc shares have risen nearly 4.85% since the year began. Nevertheless, the stocks have fallen -51.35% over the past one year. While a 52-week high of $12.02 was reached on 06/03/25, a 52-week low of $1.03 was recorded on 05/08/25. SMA at 50 days reached $1.56, while 200 days put it at $4.13.
Levels Of Support And Resistance For TNGX Stock
The 24-hour chart illustrates a support level at 2.57, which if violated will result in even more drops to 1.89. On the upside, there is a resistance level at 3.80. A further resistance level may holdings at 4.35. The Relative Strength Index (RSI) on the 14-day chart is 76.03, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.63, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 18.11%. Stochastics %K at 71.73% indicates the stock is a holding.
How much short interest is there in Tango Therapeutics Inc?
A steep rise in short interest was recorded in Tango Therapeutics Inc stocks on 2025-05-15, growing by 2.52 million shares to a total of 13.75 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 11.24 million shares. There was a rise of 18.29%, which implies that there is a positive sentiment for the stock.
